Important Notices

On October 25, 2019, Novitium Pharma LLC (Novitium) issued a voluntary recall of Ranitidine 150mg capsules, and 300mg capsules due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.

On October 23, 2019, Dr. Reddy’s Laboratories Ltd. issued a voluntary recall of all of its ranitidine medications due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.

 

Updated: 10/30/19

On October 22, 2019, Sanofi issued a voluntary recall of Zantac OTC (over-the-counter) products due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.

Express Scripts will mail letters to patients who have received medication impacted by the recall.

The FDA recommends speaking with your prescriber if you want to stop your medication or use an alternative medication.

Zantac OTC (over-the-counter) Products:

Zantac 150®

Zantac 150® Cool Mint

Updated: 10/30/19

On September 23, 2019, Sandoz, Inc. announced issued a voluntary recall of all lots of Ranitidine capsules due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.

Express Scripts will mail letters to patients who have received medication impacted by the recall.

The FDA recommends speaking with your prescriber if you want to stop your medication or use an alternative medication.

We can help you get your medicine

Due to the National Defense Authorization Act (NDAA), copayments are changing.

On September 23 2019, Sandoz, Inc, announced a voluntary recall of Ranitidine 150mg and 300mg capsules.